Sep 2026· Clinical pharmacology and therapy· 0 citations· 8 references
Medicine
TL;DR
Specific laboratory practices that should be discontinued or established and followed as standard practice are proposed and ideal practices that would advance pharmacogenomics in clinical care are proposed.
Abstract
Commercial laboratories often have differing approaches to pharmacogenomic testing, which detects the presence of germline genetic variants associated with drug response. Setting standards for clinical laboratories and defining criteria for clinicians to consider when choosing a testing laboratory can help maximize the benefits of pharmacogenomics. Here, we propose specific laboratory practices that should be discontinued or established and followed as standard practice. We also propose ideal practices that would advance pharmacogenomics in clinical care.
Give the same dose of the same drug to two patients, and one may be cured while the other is harmed—a problem as old as prescribing itself. Much of that variability is written in the genome. Pharmacogenetics, the study of how inherited variation modifies drug response, has matured from a laboratory curiosity into a...
J. Sikarwar, Zunaira Amber, Nada Mohamme et al.· International Journal For Mu...· 0 citations
This work proposes a framework using genotype-stratified trials to characterize pharmacogenetic sources of variability, informing MIDD and MPID models while helping identify additional determinants of therapeutic response in CMC.
R. Gelineau-Morel, J. Leeder, Jonathan B. Wagner· Clinical pharmacology and th...· 0 citations
The Danish strategy for personalised medicine 2025-2027 includes initiatives for improving the use of pharmacogenetic information to guide drug therapy, and this review emphasises the need for improved infrastructure and data access for physicians.
M. Bentsen, J. Bundgaard, N. Brøns et al.· Ugeskrift for læger· 0 citations
Clinical pharmacogenomics (PGx) is an emerging component of precision medicine that examines how inherited genetic variation influences an individual's response to medicines. Genetic differences affecting drug-metabolizing enzymes, transporters, receptors, immune pathways and therapeutic targets can contribute to inter...
Kalyani R· Bulletin of Advanced Drug De...· 0 citations
INTRODUCTION
Pharmacogenetics is pivotal in modern HIV management, facilitating the transition from the traditional "one-size-fits-all" model toward personalized precision medicine. By analyzing how unique genetic profiles influence pharmacological responses, clinicians can maximize therapeutic efficacy while minimizin...